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IK is known to inhibit the expression of major histocompatibility complex (MHC) class II antigen,
but other cellular functions of IK remain to be uncovered. In this study, IK depletion caused mis-
alignment of chromosomes through an increase in Aurora A and PLK1 phosphorylation, which
was mediated by a decrease in PP1 and PP2A activities. On the other hand, the treatment of a dual
inhibitor against CDK and Aurora kinases overrode IK depletion-induced mitotic arrest through the
activation of phosphatase activity. These ﬁndings imply that IK is an essential protein for achieving
correct mitotic progress through the regulation of mitotic kinases and phosphatases.
Structured summary of protein interactions:
CIP2A physically interacts with IK by anti bait coip (View interaction)
Aurora A physically interacts with IK by anti tag coimmunoprecipitation (View interaction)
IK physically interacts with Aurora A by anti bait coip (1, 2)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction TPX2 [13], which interacts with Aurora A and protects theAurora A expression is highly increased in a variety of human
cancers and Aurora A overexpression increases the malignancy of
cancer cells through the defective cytokinesis and aneuploidy [1–
9]. CDK1 is an upstream kinase for Aurora A activation and protein
phosphatase 1 (PP1) blocks Aurora A activation by the dephospho-
rylation of Thr288 residue. Upon CDK1 activation at G2/M transi-
tion, CDK1 inactivates PP1 by inhibitory phosphorylation of
Thr320 residue and this event results in the PLK activation by Aur-
ora A. Aurora A and PLK1 are also required full activation of CDK1
[10]. Thus, this sequential activation contributes to a positive feed-
back loop by which mitotic entry begins at proper time.
Aurora A activity peaks at the G2/M transition during cell cycle
and the active Aurora A plays an essential role in centrosome mat-
uration and spindle assembly [11]. The phosphorylation of Thr288
residue in Aurora A is required for the autoactivation, and the
phosphorylation of this residue increases the rate of catalysis and
also prevents rebinding of the inhibitory protein kinase A regula-
tory subunit [12]. Aurora A can be also regulated by a co-activatordephosphorylation of Thr288 from PP1 [14,15]. Protein phospha-
tases family includes PP1, PP2A, PP4, PP6, PP2B, PP5, and PP7, which
all speciﬁcally dephosphorylate serine and threonine residues [16].
PP1, PP2A, and PP6 are involved in the proper cell cycle progression
through dephosphorylating key mitotic kinases during G2/M [17–
21]. In addition to the regulation of mitotic kinases, PP1 and PP2A
also dephosphorylate their substrates, which are phosphorylated
by mitotic kinases, for the exact cell cycle progression [22].
Human IK cytokine is known to inhibit interferon gamma-
induced expression of major histocompatibility complex (MHC)
class II antigen during the immune response [23,24] and plays
a role in CD34+ cell proliferation and differentiation [25].
Recently, systemic approaches have identiﬁed that depletion of
IK induces abnormal mitosis leading to cell death [26]. Here,
we investigated the effect of IK depletion on cell cycle progres-
sion. IK bound to Aurora A and suppressed its activity by regulat-
ing phosphatases.
2. Materials and methods
2.1. Cell cultures and RNA interference
Human HeLa, H2B-GFP HeLa, and HEK 293T cells were
maintained in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM)
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(HyClone Laboratories, UT, USA). HeLa cells were treated with
inhibitors of Aurora A (MLN8237 at 2 lM), CDK1 (RO3306 at
1 lM), PLK1 (BI2536 at 100 nM), and CDK/Aurora (JNJ-7706621
at 10 lM). To measure the time of mitotic phase, cells were mon-
itored at an interframe of 15 min (Juli Cell Analyzer, Erlangen, Ger-
many). The following sequences were used for the depletion of IK
expression (#1, 50-GAAGAAACCGAGCUUAUCA-30; #2, 50-
CUACCAAGGAGUUGAUCAA-30; and #3, 50-GCAUUCCAGUAUGGUA-
UCA-30) and transfection was performed with mixtures of each siR-
NA (ﬁnal concentration, 20 nM). Control siRNAs were purchased
from Dharmacon Research (CO, USA).
2.2. Plasmids and antibodies
The human full-length IK gene was obtained from Addgene
(MA, USA) and the mouse full-length IK gene (mIK) was obtained
from Open Biosystems (AL, USA). Expression plasmids of GST-
Aurora A and FLAG-PLK1 were obtained from Dr. Changwoo Lee
at the Sungkyunkwan University School of Medicine. The follow-
ing antibodies were obtained from commercial sources: IK, Cyclin
B1, Bcl-2, b-actin, Bax, CDK1, and PP1 antibodies (Santa Cruz Bio-
technology, CA, USA); caspase 7, PARP, pAurora A Thr288, pCDK1
Tyr15, vimentin, and pPP1a Thr320 antibodies (CST, MA, USA);
Aurora A, PLK1, pPLK1 Thr210, TPX2, GST, pCDK1 Thr14, CENP-
A, and pPP2A Tyr307 antibodies (Abcam, MA, USA); a-tubulin
and FLAG antibodies (Sigma, MO, USA); PP6 antibodies (Bethyl
Laboratories, TX, USA); BubR1 antibody (BD Pharmingen, CA,
USA); pH3S10 and PP2A antibodies (Upstate Biotechnology, NY,
USA).
2.3. Immunoﬂuorescence
HeLa cells were seeded on coverslips and ﬁxed with 20 C
methanol for 5 min at the time of experiment. The coverslips were
blocked using PBS-BT (3% BSA and 0.1% Triton X-100) for 30 min at
room temperature, immunostained for 2 h with antibodies at room
temperature, and then immunostained for 1 h with secondary anti-
bodies at room temperature. Images were acquired as described
previously [27].
2.4. Cell proliferation assay and cell synchronization
For the proliferation assay, HeLa cells were transfected with siIK
or human IK expression plasmid, and thenplated onto 12well plates
at a density of 1  105 cells per well. The live cells were counted
using trypanbluedye exclusionassay. Cell synchronizationwasper-
formed as previously described [27].
2.5. Immunoprecipitation and immunoblot analysis
Anti-GST, anti-FLAG, and anti-Aurora A antibodies coupled to
protein G-agarose (Roche, IN, USA), were added to 1 ml of cell
lysates. After the incubation, the lysates were washed three times
with 1 ml of cold buffer (50 mM Tris–HCl pH 7.5, 0.5% Igepal CA-
630, 0.5 mM EDTA, and 150 mM NaCl). Immunoblot analysis was
performed as previously described [27].
2.6. FACS analysis
Cells were ﬁxed with 70% ethanol, and then simultaneously
stained with an anti-pH3S10 antibody and PI buffer (50 lg/ml
propidium iodide, 10 mM Tris–HCl pH 7.5, 5 mM MgCl2, and
200 lg/ml RNase A) for 1 h at 37 C. The stained cells were ana-
lyzed on a FACSCanto II cytometer using FACSDiva software (BD
Bioscience, CA, USA).2.7. Aurora A kinase assay
For the in vitro kinase reaction, IK protein was synthesized by
an in vitro transcription–translation reaction TNT system
(Promega, WI, USA). The translated IK was incubated with 0.3 lg
of active recombinant Aurora A, 50 lM ATP and 1 lg of MBP pro-
tein substrate, and then incubated for 40 min at room temperature.
Kinase activity was measured using an ADP-Glo kinase assay kit
(Promega, WI, USA).
3. Results
3.1. IK depletion induces mitotic arrest and apoptosis
In an attempt to ﬁnd regulatory proteins against cancerous
inhibitor of protein phosphatase 2A (CIP2A), which is involved in
cell cycle progression through the regulation of centrosome sepa-
ration, mitotic spindle dynamics, and polo-like kinase 1 (PLK1)
[27,28], yeast two-hybrid screening system was employed. Among
them, we focused on IK because IK is known to be increased in
tumor patient’s serum and CIP2A is also increased in tumor tissues.
To further conﬁrm whether CIP2A binds to IK in mammalian cells,
HA-tagged IK and CIP2A expression plasmids were simultaneously
transfected into HEK 293T cells and then immunoprecipitated with
an anti-CIP2A antibody. HA-tagged IK bound strongly to CIP2A
(Fig. 1A). To ﬁnd out whether IK affects CIP2A expression, HeLa
cells were transfected with siIK and then CIP2A level was exam-
ined. CIP2A expression was clearly decreased in IK-depleted cells
(Fig. 1B). Because CIP2A is known to increase the proliferation of
cancer cells [29], it is possible for IK-depleted cells to show the
decreased proliferation. Expectedly, the proliferation of IK-
depleted cells was decreased (Fig. 1C). Next, to determine whether
overexpression of IK increases cell proliferation, cell proliferation
rate was examined using IK overexpressing HeLa cells. The
overexpression of IK did not affect cell proliferation (Fig. 1D), indi-
cating that the endogenous level of IK expression is enough for its
function.
Because CIP2A is involved in the cell cycle regulation and
previous work in phenotyping analysis by live-cell imaging after
siRNA depletion of the human genome show that IK depletion
induces cell death [26], HeLa cells stably expressing H2B-GFP were
transfected with siIK and cell cycle progression was monitored
using the time-lapse ﬂuorescence microscopy. Control cells
divided into two daughter cells within 90 min, whereas IK-depleted
cells failed to divide even until 375 min after entering mitosis
(Fig. 1E). When division time was measured with 10 IK-depleted
cells, percent of mitotic delay was increased (Fig. 1F). To prove that
siIK do not have off-target effects, HeLa cells were cotransfected
with siIK and mouse IK-expressing plasmid and then the mitotic
phase population was analyzed 48 h after transfection. Mitotic
arrest induced by siIK was resolved by the overexpression of mouse
IK (Fig. 1G). Because long delay ofmitosis usually leads to apoptosis,
cell lysates were prepared 48 and 72 h after siIK transfection and
levels of apoptotic marker including Bcl2, Bax, and PARP were
examined. IK-depleted cells underwent apoptosis 72 h after IK
depletion (Fig. 1H). Because IK depletion itself shows severe defect
in cell cycle, we focused on the role of IK in mitosis later on.
3.2. IK depletion enhances the phosphorylation of Aurora A and PLK1
Because the phenotypes caused by IK depletion were
consistently similar to those caused by aberrant Aurora A and
PLK1 [30,31], we examined the localization and intensity of Aurora
A and PLK1, which control centrosome maturation and spindle
assembly. Aurora A localization to centrosomes was not affected
by IK depletion, but the intensity of phosphorylated Aurora A at
Fig. 1. IK depletion causes mitotic arrest. (A) HEK 293T cells were transfected with CIP2A and HA-tagged IK, and then immunoprecipitated with an anti-CIP2A antibody. The
anti-CIP2A and anti-HA antibodies were used for the immunoblot assay. (B) HeLa cells were transfected with siIK and immunoblotted at the indicated time points using anti-
IK and anti-CIP2A antibodies. (C) HeLa cells were transfected with siIK, and cell numbers were counted at the indicated time points. IK depletion was conﬁrmed by
immunoblot assay. (D) HeLa cells were transfected with human FLAG–IK expression plasmid and cell numbers were counted at the indicated time points. FLAG–IK expression
was conﬁrmed by immunoblot assay. (E) HeLa cells stably expressing H2B-GFP were transfected with siIK for 48 h, and the cell morphology was observed with time-lapse
ﬂuorescence microscopy at 15 min intervals. The numbers indicate the time point after mitotic entry and the white arrows indicate misaligned chromosomes. (F) Cells
expressing H2B-GFP were transfected with siIK and the mitotic timing was recorded using time-lapse microscopy 48 h after transfection. According to mitotic duration, the
mitotic cells were classiﬁed into three types: fail to divide: cells cannot divide for 6 h after entering mitosis; <180: cells can divide within 180 min after entering mitosis; <90:
and cells can divide within 90 min. (G) HeLa cells were cotransfected with siIK and mouse IK expressing plasmid (mIK), and then stained with a propidium iodide (PI) solution
and FITC-conjugated anti-pH3S10 antibody. The cell population was analyzed using ﬂow cytometry and double positive are considered as mitotic phase cells. (H) The lysates
obtained from (B) were immunoblotted using antibodies against apoptotic markers.⁄P < 0.05, ⁄⁄⁄P < 0.001.
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localization (Fig. 2A). PLK1 localizes to centrosomes and the
kinetochore region [32]. PLK1 localization was not affected by IK
depletion. However, the phosphorylated PLK1 at Thr210 was
increased in IK-depleted cells, without any changes in its localiza-
tion to the kinetochore region (Fig. 2B). To further conﬁrm the
enhanced phosphorylation of Aurora A and PLK1 in IK-depleted
cells, the levels of phosphorylated Aurora A and PLK1 were exam-
ined by immunoblot assay. The phosphorylation of Aurora A and
PLK1 was enhanced (Fig. 2C), consistent with immunoﬂuorescence
microscopy images. The increase of the phosphorylated Aurora A
and PLK1 would be associated with misaligned chromosomes in
IK-depleted cells. On the other hand, the level of PLK1 and Aurora
A was increased in IK-depleted cells because of the increase in
mitotic cell population. Next, to determine whether overexpres-
sion of IK affects Aurora A phosphorylation, HeLa cells were
transfected with human FLAG-IK expression plasmid. The phos-
phorylation level of Aurora A was not increased (Fig. 2D).
3.3. IK interacts with Aurora A
To determine whether IK binds to Aurora A, GST-tagged Aurora
A and FLAG-tagged PLK1 were expressed in HEK 293T cells and
then immunoprecipitated using anti-GST and anti-FLAG antibod-
ies. Aurora A bound to endogenous IK (Fig. 3A), but not toFLAG-PLK1 (Fig. 3B). To determine at which phase Aurora A
strongly binds to IK during cell cycle progression, a double thymi-
dine block (DTB) release experiment was performed. The cyclin B1
level was measured as a marker of cell cycle progress. Aurora A
expression peaked at G2/M transition [33], but it was reduced after
the mitosis. Aurora A was co-immunoprecipitated with IK during
from early G2 to late phase of mitosis, and vice versa (Fig. 3C).
To determine whether the phosphorylated Aurora A is an active
kinase in IK-depleted cells, the phosphorylation level of Aurora A
speciﬁc substrate H3S10 was examined by immunoblot assay
[34]. The phosphorylation of H3S10 was increased. In addition to
the increase of pH3S10, expression levels of Aurora A speciﬁc sub-
strates Vimentin and CENP-A were also increased (Fig. 3D). These
ﬁndings imply that the phosphorylated Aurora A in IK-depleted
cells is functionally active. Next, to examine whether IK directly
affects Aurora A activity, in vitro-translated IK was mixed with
recombinant Aurora A and then the activity was measured. The
Aurora A activity was decreased in the presence of IK, indicating
that IK directly suppresses Aurora A activity (Fig. 3E).
3.4. IK depletion enhances Aurora A activity through inhibition
of protein phosphatases
To compare Aurora A activity and levels between control and
IK-depleted cells during cell cycle progression, DTB and release
Fig. 2. IK depletion activates Aurora A and PLK1. (A, B) HeLa cells were transfected with siIK for 48 h and then stained with anti-Aurora and anti-pAurora A Thr288 (A) or anti-
PLK1 and anti-pPLK1 Thr210 antibodies (B). (C) Lysates obtained from IK-depleted cells 48 h after siIK transfection were analyzed using antibodies against Aurora A, pAurora
A Thr288, PLK1, and pPLK1 Thr210. The white arrows indicate misaligned chromosomes. (D) HeLa cells were transfected with human FLAG-IK expression plasmid. The level of
Aurora A and pAurora A Thr288 was analyzed using immunoblot assay. Scale bars = 5 lm.
Fig. 3. IK interacts with Aurora A. (A) HEK 293T cells were transfected with GST-Aurora A and then immunoprecipitated with an anti-GST antibody. The anti-IK and anti-GST
antibodies were used for the immunoblot assay. (B) HEK 293T cells were transfected with FLAG-PLK1, and the lysates were immunoprecipitated with an anti-FLAG antibody.
Anti-IK and anti-FLAG antibodies were used for the immunoblot assay. (C) HeLa cells were synchronized by DTB and released. The lysates from indicated time points were
immunoprecipitated using an anti-Aurora A and anti-IK antibodies, and then anti-IK, anti-Aurora A, and anti-Cyclin B1 antibodies were used for the immunoblot assay. (D)
Lysates obtained from IK-depleted cells 48 h after siIK transfection were analyzed using antibodies against IK, pH3S10, vimentin, and CENP-A. (E) In vitro-translated IK was
incubated with recombinant Aurora A, and then Aurora A activity was measured. The input levels of IK and Aurora A were determined by immunoblot assay. ⁄P < 0.05.
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Fig. 4. IK depletion activates Aurora A through inactivation of protein phosphatases. (A) The top of ﬁgure indicates an experimental protocol. HeLa cells transfected with siIK
were synchronized by DTB and released. The level of IK, pAurora A Thr288, Aurora A, and Cyclin B1 were examined using an immunoblot assay. (B) HeLa cells were
transfected with siIK for 48 h, lysates were prepared, and the levels of IK, PP1, TPX2, pPP1a Thr320, PP1, pPP2A Tyr307, and PP2A were examined using immunoblot assay.
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the level of Aurora A between control and IK-depleted cells. How-
ever, the phosphorylated Aurora A was increased at 10 h in control
cells, whereas it was modestly increased from 0 h and peaked at
10 h after the DTB release in IK-depleted cells (Fig. 4A). These
results indicate that Aurora A is activated in IK-depleted cells ear-
lier than in control cells. Next, to determine how the Aurora A
phosphorylation is increased by IK depletion, we examined the
level of TPX2 and protein phosphatases including PP1, PP2A, PP6,
which are known to regulate Aurora A activity [12,14,21,35]. PP6
was markedly decreased in IK-depleted cells and levels of inhibi-
tory phosphorylation in PP1 and PP2A were enhanced. Moreover,
TPX2 was up-regulated after IK depletion (Fig. 4B). TPX2 is critical
for autocatalytic phosphorylation of the T288 residue in Aurora A
[21] and it prevents the dephosphorylation of this residue. Taken
together, the enhanced phosphorylation of Aurora A in IK-depleted
cells is due to the reduced protein phosphatase activity and
increased TPX2 level.
3.5. The inhibition of CDK1 and Aurora kinases overcomes IK
depletion-induced mitotic arrest without cell division
To reveal which kinase is more responsible for mitotic arrest in
IK-depleted cells, IK-depleted cells were treated with inhibitors of
Aurora A, PLK1, and CDK1 respectively, and then cellular morpho-
logical changes were monitored. Mitotic round cell shape was not
altered by the treatment (Fig. 5A). To test a possibility that other
kinases are associated with IK depletion-induced mitotic arrest,
JNJ-7706621, which is a dual inhibitor of CDK and Aurora kinases
was tested. Strikingly, JNJ-7706621 treatment markedly reduced
the mitotic round cell shape in a dose-dependent manner (Fig. 5B).
To assess whether this phenotypic change was due to a
decrease in mitotically arrested cells, JNJ-7706621-treated cells
were stained with an anti-pH3S10 antibody. There were few
pH3S10-positive cells (Fig. 5C). Thus, to examine whether the IK
depletion-induced mitotic-arrested cells shift into a G1 population
after treatment with the JNJ-7706621, the cell cycle distribution
was analyzed. Apart from our expectation, the JNJ-7706621-trea-
ted cells remained at G2/M phase without cell division (Fig. 5D).Although we were unable to completely rescue the IK
depletion-induced phenotype, this experiment suggests that IK
depletion-induced mitotic arrest is due to additionally impaired
functions of IK/CDK/Aurora kinases.
Next, to determine whether kinase inactivation by JNJ-7706621
alters phosphatase activity, the phosphorylated form of the phos-
phatases was examined after JNJ-7706621 treatment. The phos-
phorylated PP2A catalytic subunit was not affected, but the
phosphorylated PP1 catalytic subunit was signiﬁcantly reduced
by JNJ-7706621. In addition to the change in PP1 phosphorylation,
the PP6 level was also recovered by JNJ-7706621 treatment
(Fig. 5E), indicating that JNJ-7706621 increases PP1 and PP6 activ-
ities which were reduced in IK-depleted cells.
Taken together, IK binds to Aurora A and IK depletion increases
Aurora A activity by the suppression of phosphatases and TPX2
during mitosis. Moreover, the treatment with the JNJ-7706621
decreased mitotic phosphorylation by recovering PP1 and PP6
activity without division.
4. Discussion
Because IK depletion impaired proper alignment of chromo-
somes during metaphase without affecting centrosome disjunc-
tion, we focused on Aurora A and PLK1 kinase, instead of Nek2A
that regulates centrosome disjunction [36,37]. Aurora A is required
for centrosome maturation and spindle assembly by increasing
gamma-tubulin in the centrosome, and PLK1 controls the localiza-
tion of Aurora A to centrosomes [33,38]. Thus, Aurora A and PLK1
interact to allow correct centrosome maturation and spindle for-
mation [39]. In this study, IK-depleted cells were arrested in mito-
tic phase because of misaligned chromosomes. The enhanced
Aurora A and PLK1 activities may affect improper mitotic spindle
formation, leading to misaligned chromosomes. IK is not likely to
enhance PLK1 activity directly because IK did not bind to PLK1.
Instead, activated Aurora A in IK-depleted cells may elevate PLK1
activation through phosphorylating Thr210 residue on the T loop
of PLK1 in early mitosis [40,41].
The depletion of IK activated Aurora A, because the physical
interaction between IK and Aurora A led to the suppression of Aur-
Fig. 5. IK-depleted cells pass mitotic arrest without cell division by chemical inhibitor JNJ-7706621 treatment. (A, B) The top of ﬁgure indicates an experimental protocol.
HeLa cells were transfected with siIK for 45 h and then treated with the indicated inhibitor for 3 h. The shape of cells was photographed using light microscopy. (C) The cells
from (B) were stained with an anti-pH3S10 antibody and pH3S10-positive cells were measured using ﬂow cytometry. (D) The cells from (B) were also stained with PI. The cell
cycle was analyzed using ﬂow cytometry. Flow cytometry data were analyzed using FlowJo software. (E) The cells were transfected with siIK for 45 h and then treated with
the indicated concentration of JNJ-7706621 for 3 h. The lysates were analyzed with antibodies against IK, Cyclin B1, pCDK1 Tyr15, pCDK1 Thr14, CDK1, pPP1a Thr320, PP1,
pPP2A Tyr307, PP2A, and PP6. ⁄⁄P < 0.01, ⁄⁄⁄P < 0.001. Scale Bar = 50 lm.
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by IK interaction, the depletion of IK caused to prolonged Aurora A
activity through the decrease of PP6 expression and PP1/PP2A
activities. The inactivated protein phosphatases failed to dephos-
phorylate Aurora A and its substrates, resulting in the hyperactiva-
tion of Aurora A. However, Aurora A inhibition failed to exit from
mitotic arrest caused by IK depletion. In general, inhibition of
CDK1 after mitotic entry induces premature mitotic exit and
changes cell shape into a ﬂat morphology without cell division
[42,43], but IK-depleted cells did not exit from mitotic arrest by
CDK1 inhibition alone (Fig. 5A). On the other hand, the dual inhibi-
tion of CDK1 and Aurora kinases changed mitotic round shape of
cells into ﬂat shape, but failed to divide. These results imply that
activation or inhibition of other kinases would be required for
the recovery of IK depletion-induced mitotic arrest in addition to
CDK1 and Aurora kinases.
The phosphorylation of PP1a at Thr320 by CDK1 causes PP1
inactivation and results in a sequential activation of Aurora A and
PLK1 [44]. Thus, CDK1 initiates mitotic entry through activating
Aurora A and PLK1. However, the simultaneous inactivation of both
Aurora A and PLK1 markedly delays CDK1 activation and entry into
mitosis [6]. It indicates that Aurora A and PLK1 participate in an
activation feedback loop of CDK1. In present study although we
failed to completely recover mitotic arrest induced by IK depletion,
it is clear that improper sequential activation of mitotic kinases is
one of causes which induced mitotic arrest in IK-depleted cells.
Therefore, it is conceivable that the simultaneous suppression of
kinaseswith JNJ-7706621 treatment failed to recovermitotic arrest,
because CDK1, PLK1, and Aurora kinase play an important role on
mitotic progress through a sequential activation loop.In summary, the suppressed activity of PP1/PP2A and the
decreased PP6 level in IK-depleted cells contribute to the sustained
activity of Aurora A, which is one of the causes of the mitotic arrest.
Because the treatment of a dual inhibitor against CDK and Aurora
kinases overrides IK-depletion-induced mitotic arrest without cell
division, other Aurora kinases and CDK are related to mitotic arrest
in IK-depleted cells. Thus, the elucidation of the detailed mecha-
nism by which CDK and Aurora kinases induce mitotic arrest in
IK-depleted cells will improve our understanding about IK cellular
function.
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